NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 761 / 982

  1. Gas chromatographic analysis of dimethyltryptamine and β‐carboline alkaloids in ayahuasca, an amazonian psychoactive plant beverage2009 · OpenAlex
  2. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior2009 · OpenAlex
  3. GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence.2009 · PubMed
  4. GDNF--a potential target to treat addiction.2009 · PubMed
  5. Gender and alcohol consumption: patterns from the multinational GENACIS project2009 · OpenAlex
  6. Gender and locality differences in tobacco prevalence among adult Bangladeshis2009 · Crossref
  7. Gender and the relationship between marital status and first onset of mood, anxiety and substance use disorders2009 · OpenAlex
  8. Gender differences in the use of anxiolytics and antidepressants: a population based study2009 · Crossref
  9. Gene expression changes following extinction testing in a heroin behavioral incubation model2009 · OpenAlex
  10. General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints2009 · Crossref
  11. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities2009 · Crossref
  12. Genetic contributions of the serotonin transporter to social learning of fear and economic decision making2009 · OpenAlex
  13. Genetic determinants of both ethanol and acetaldehyde metabolism influence alcohol hypersensitivity and drinking behaviour among Scandinavians2009 · Crossref
  14. Genetic Differences among C57BL/6 Substrains2009 · OpenAlex
  15. GENETIC STUDY: 5‐HTTLPR polymorphism, mood disorders and MDMA use in a 3‐year follow‐up study2009 · OpenAlex
  16. Genetical genomic determinants of alcohol consumption in rats and humans2009 · OpenAlex
  17. Genetically Determined Interaction between the Dopamine Transporter and the D2Receptor on Prefronto-Striatal Activity and Volume in Humans2009 · OpenAlex
  18. Gene–environment interactions and alcohol use and dependence: current status and future challenges2009 · Crossref
  19. Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors2009 · OpenAlex
  20. Geographical information systems as a tool for monitoring tobacco industry advertising2009 · Crossref
  21. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users2009 · OpenAlex
  22. Girl Power: Risky Sexual Behaviour and Gender Identity amongst Young Spanish Recreational Drug Users2009 · OpenAlex
  23. GIRLS, BOYS, AND SCHOOLS: GENDER DIFFERENCES IN THE RELATIONSHIPS BETWEEN SCHOOL‐RELATED FACTORS AND STUDENT DEVIANCE*2009 · Crossref
  24. Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling2009 · OpenAlex
  25. Global Nomads: Techno and New Age as Transnational Countercultures in Ibiza and Goa (D'Andrea)2009 · OpenAlex
  26. Glossolalia influences on stress response among Apostolic Pentecostals2009 · OpenAlex
  27. Granules Composed of Cocoa Pod Husk Enriched with Minerals and Their Effects on Growth of Coffee and Cocoa Seedlings2009 · Crossref
  28. Guns, crime and social order in the West Indies2009 · OpenAlex
  29. Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior2009 · OpenAlex
  30. Harm Reduction in an Open Drug Scene2009 · Crossref
  31. Harm reduction in hospitals: is it time?2009 · Crossref
  32. HARM REDUCTION IN THE UNITED STATES AT A MOMENT OF CHANGE: MOVING INNOVATION FROM GRASSROOTS TO MAINSTREAM?2009 · OpenAlex
  33. HARM REDUCTION IS A GOOD LABEL FOR A CRITERION ALL DRUG PROGRAMS SHOULD MEET2009 · OpenAlex
  34. Harm Reduction: Aspects of Prevention and Handling of Drug Addict Emergencies2009 · Crossref
  35. Harm Reduction: The Case of Switzerland2009 · Crossref
  36. HARM REDUCTION—AN ETHICAL IMPERATIVE2009 · OpenAlex
  37. Harms associated with psychoactive substances: findings of the UK National Drug Survey2009 · OpenAlex
  38. HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine.2009 · PubMed
  39. Health Consequences of Childhood Sexual Abuse2009 · OpenAlex
  40. Health consequences of illegal drug use2009 · OpenAlex
  41. Health outcomes of youth development programme in England: prospective matched comparison study2009 · OpenAlex
  42. Health Services Research for Drug and Alcohol Treatment and Prevention2009 · Crossref
  43. Heavy Episodic Drinking and Alcohol Consumption in French Colleges: The Role of Perceived Social Norms2009 · OpenAlex
  44. HEDIS Initiation and Engagement Quality Measures of Substance Use Disorder Care: Impact of Setting and Health Care Specialty2009 · Crossref
  45. HEPATITIS C AND ADDICTION: Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction2009 · Crossref
  46. HEPATITIS C AND ADDICTION: Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha‐2a and ribavirin in opioid‐dependent patients2009 · Crossref
  47. Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?2009 · OpenAlex
  48. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection2009 · Crossref
  49. Heritability of Risk-Taking in Adolescence: A Longitudinal Twin Study2009 · OpenAlex
  50. Heroin addiction in African Americans: a hypothesis‐driven association study2009 · OpenAlex
  51. Heroin Overdose Deaths and Heroin Purity Between 1990 and 2000 in Istanbul, Turkey*2009 · OpenAlex
  52. Heroin‐assisted treatment in Switzerland: a case study in policy change2009 · Crossref
  53. High-Dose Glycine Treatment of Refractory Obsessive-Compulsive Disorder and Body Dysmorphic Disorder in a 5-Year Period2009 · OpenAlex
  54. High-temperature beverages and foods and esophageal cancer risk--a systematic review.2009 · PubMed
  55. High‐throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains2009 · OpenAlex
  56. Historical Images and Reviews of Substance Use and Substance Abuse in the Teaching of Addiction Studies2009 · Crossref
  57. Historical overview of psychoactive mushrooms2009 · OpenAlex
  58. History of falls in Parkinson disease is associated with reduced cholinergic activity2009 · OpenAlex
  59. HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey2009 · Crossref
  60. HIV infection and psychiatric illness2009 · OpenAlex
  61. HIV prevention and psychoactive drug use: a research agenda2009 · Crossref
  62. HIV Risks and Seroprevalence Among Mexican American Injection Drug Users in California2009 · OpenAlex
  63. HIV-1 Prevalence among Drug Abuse-Related Deaths in Europe (1993)2009 · Crossref
  64. HIV/AIDS in Vancouver, British Columbia: a growing epidemic2009 · Crossref
  65. Homeostatic mechanisms in dopamine synthesis and release: a mathematical model2009 · OpenAlex
  66. Homicide in Chicago from 1890 to 1930: prohibition and its impact on alcohol‐ and non‐alcohol‐related homicides2009 · Crossref
  67. Homonegativity, Substance Use, Sexual Risk Behaviors, and HIV Status in Poor and Ethnic Men Who Have Sex with Men in Los Angeles2009 · OpenAlex
  68. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia2009 · OpenAlex
  69. Hookah (Shisha, Narghile) Smoking and Environmental Tobacco Smoke (ETS). A Critical Review of the Relevant Literature and the Public Health Consequences2009 · Crossref
  70. Hormones and drinking behaviour: New findings on ghrelin, insulin, leptin and volume‐regulating hormones. An ESBRA Symposium report2009 · Crossref
  71. Hours and Days of Sale and Density of Alcohol Outlets: Impacts on Alcohol Consumption and Damage: A Systematic Review2009 · OpenAlex
  72. HOW BROADLY DOES EDUCATION CONTRIBUTE TO JOB PERFORMANCE?2009 · OpenAlex
  73. How confident should we be that smoking cessation treatments work?2009 · Crossref
  74. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale2009 · OpenAlex
  75. How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous2009 · OpenAlex
  76. How does sexual minority stigma "get under the skin"? A psychological mediation framework.2009 · PubMed
  77. Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease2009 · OpenAlex
  78. Hypoglycemic herbs and their action mechanisms2009 · OpenAlex
  79. Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease2009 · OpenAlex
  80. Identification and Characterization of Kava‐derived Compounds Mediating TNF‐α Suppression2009 · Crossref
  81. Identification and fragmentation pathways of caffeine metabolites in urine samples via liquid chromatography with positive electrospray ionization coupled to a hybrid quadrupole linear ion trap (LTQ) and Fourier transform ion cyclotron resonance mass spectrometry and tandem mass spectrometry2009 · Crossref
  82. Identification and Quantitation of Amphetamines, Cocaine, Opiates, and Phencyclidine in Oral Fluid by Liquid Chromatography—Tandem Mass Spectrometry2009 · OpenAlex
  83. Identification of a cannabinoid analog as a new type of designer drug in a herbal product.2009 · PubMed
  84. Identification of adulterants added to beeswax: Estimation of detectable minimum percentages2009 · OpenAlex
  85. Identification of candidate genes affecting Δ9-tetrahydrocannabinol biosynthesis in Cannabis sativa2009 · OpenAlex
  86. Identification of endogenous acyl amino acids based on a targeted lipidomics approach2009 · OpenAlex
  87. Identification of Psilocybe cubensis Spore Allergens by Immunoprinting2009 · Crossref
  88. Identification of the Allergen Psi c 2 from the Basidiomycete Psilocybe cubensis as a Fungal Cyclophilin2009 · Crossref
  89. Identifying experimental methods to determine the effect of pain on attention: a review of pain, caffeine, alcohol and nicotine studies2009 · Crossref
  90. Identifying New Cannabis Use with Urine Creatinine-Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections2009 · OpenAlex
  91. Identifying PTSD personality subtypes in a workplace trauma sample2009 · Crossref
  92. If cannabis caused schizophrenia—how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations2009 · Crossref
  93. Illegal Route Estimation of the Seized Illicit Drug, Methamphetamine, by the Comparison of Striation Marks on Plastic Packaging Films2009 · Crossref
  94. Imaging dopamine's role in drug abuse and addiction.2009 · PubMed
  95. Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology2009 · OpenAlex
  96. Imaging-based Quantification of Hepatic Fat: Methods and Clinical Applications2009 · OpenAlex
  97. Imipramine Treatment and Resiliency Exhibit Similar Chromatin Regulation in the Mouse Nucleus Accumbens in Depression Models2009 · OpenAlex
  98. Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression2009 · OpenAlex
  99. Immunologic Aspects of Chronic Obstructive Pulmonary Disease2009 · OpenAlex
  100. Impact of Alcohol Advertising and Media Exposure on Adolescent Alcohol Use: A Systematic Review of Longitudinal Studies2009 · OpenAlex